Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures

OBJECTIVE: The objective of this study was to identify problems in the approval, pharmacovigilance, and post-approval regulatory decision-making procedures involving gefitinib and to propose countermeasures to prevent further drug-induced suffering in Japan in the future. METHODS: We comprehensively...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Tsutomu, Tada, Harue, Nakagawa, Masatsugu, Teramukai, Satoshi, Matsui, Shigeyuki, Fukushima, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2006
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155619/
https://www.ncbi.nlm.nih.gov/pubmed/25214906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155619/
https://www.ncbi.nlm.nih.gov/pubmed/25214906

Ejemplares similares